Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Salona Global Medical Device Corporation
  6. Summary
    SGMD   CA79549X1096

SALONA GLOBAL MEDICAL DEVICE CORPORATION

(SGMD)
  Report
Delayed Bourse de Toronto  -  03:31 2022-12-02 pm EST
0.5900 CAD   -1.67%
12/01Salona Global Medical Announces US$10 Million Debenture Offering
MT
12/01Salona Global Announces Private Placement of up to US$10 Million of Debenture Units
GL
11/29Salona Global Executes Binding Agreement to Acquire Physical Medicine Assets of Biodex Medical Systems
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Bourse De Toronto
11/28/2022 11/29/2022 11/30/2022 12/01/2022 12/02/2022 Date
0.68(c) 0.72(c) 0.69(c) 0.6(c) 0.59(c) Last
57 270 42 160 30 766 141 758 148 619 Volume
-1.45% +5.88% -4.17% -13.04% -1.67% Change
More quotes
Estimated financial data (e)
Sales 2023 51,1 M 37,9 M 37,9 M
Net income 2023 0,37 M 0,27 M 0,27 M
Net Debt 2023 - - -
P/E ratio 2023 19,7x
Yield 2023 -
Sales 2024 63,7 M 47,3 M 47,3 M
Net income 2024 5,98 M 4,44 M 4,44 M
Net Debt 2024 - - -
P/E ratio 2024 4,92x
Yield 2024 -
Capitalization 32,5 M 24,1 M 24,1 M
Capi. / Sales 2023 0,64x
Capi. / Sales 2024 0,51x
Nbr of Employees 103
Free-Float 76,0%
More Financials
Company
Salona Global Medical Device Corporation is an acquisition-oriented medical technology company. The Company operates through various wholly owned United States subsidiaries. It is engaged in the production and sale of medical devices and products, certain of which are proprietary and white label. Its products include devices used for pain management, cold and hot therapy, neuromuscular electrical stimulation (NMES),... 
More about the company
Ratings of Salona Global Medical Device Corporation
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SALONA GLOBAL MEDICAL DEVICE CORPORATION
12/01Salona Global Medical Announces US$10 Million Debenture Offering
MT
12/01Salona Global Announces Private Placement of up to US$10 Million of Debenture Units
GL
11/29Salona Global Executes Binding Agreement to Acquire Physical Medicine Assets of Biodex ..
MT
11/29IIROC Trading Resumption - SGMD
AQ
11/29Salona Global Executes Binding Agreement to Acquire the Physical Medicine Assets of Bio..
GL
11/29IIROC Trading Halt - SGMD
AQ
11/29Salona Global Medical Device Corporation entered into a binding agreement to acquire Ph..
CI
10/18Salona Global Announces Second Quarter Results, Posts 153% Year-Over-Year Revenue Growt..
AQ
10/17SALONA GLOBAL MEDICAL DEVICE CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
10/17Salona Global Medical Device Corporation Reports Earnings Results for the Second Quarte..
CI
10/17Salona Global Medical Device Seeks Acquisitions
CI
10/17Transcript : Salona Global Medical Device Corporation, Q2 2023 Earnings Call,..
CI
10/17Salona Global Up Near 10% After Reporting Q2 Highlights
MT
10/17Salona Global Medical Device Corp : Results of Operations and Financial Condition, Regulat..
AQ
10/17Salona Global Announces Second Quarter Results, Posts 153% Year-Over-Year Revenue Growt..
GL
More news
News in other languages on SALONA GLOBAL MEDICAL DEVICE CORPORATION
11/29Salona Global conclut un accord contraignant pour acquérir les actifs de médecine physi..
10/17Salona Global Medical Device Corporation annonce ses résultats pour le deuxième trimest..
10/17Salona Global Medical Device recherche des acquisitions
10/17Salona Global en hausse de près de 10 % après la publication des faits saillants du deu..
10/05Salona Global Medical Device fait le point sur une commande de 7,5 millions de dollars ..
More news
Chart SALONA GLOBAL MEDICAL DEVICE CORPORATION
Duration : Period :
Salona Global Medical Device Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 0,59 CAD
Average target price 2,50 CAD
Spread / Average Target 324%
EPS Revisions
Managers and Directors
Luke T. Faulstick Chief Executive Officer & Executive Director
Dennis T. Nelson Chief Financial Officer
Leslie H. Cross Executive Chairman
Kenneth B. Kashkin Independent Non-Executive Director
Kyle Wilks Independent Non-Executive Director
Sector and Competitors